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Background: Sepsis commonly causes intensive care unit (ICU) mortality, yet early identification of adults
with sepsis at risk of dying in the ICU remains a challenge.
Objective: The aim of the study was to derive a mortality prediction model (MPM) to assist ICU clinicians
and researchers as a clinical decision support tool for adults with sepsis within 4 h of ICU admission.
Methods: A cohort study was performed using 500 consecutive admissions between 2014 and 2018 to an
Australian tertiary ICU, who were aged 18 years and had sepsis. A total of 106 independent variables
were assessed against ICU episode-of-care mortality. Multivariable backward stepwise logistic regression
derived an MPM, which was assessed on discrimination, calibration, fit, sensitivity, specificity, and
predictive values and bootstrapped.
Results: The average cohort age was 58 years, the Acute Physiology and Chronic Health Evaluation III-j
severity score was 72, and the case fatality rate was 12%. The 4-Hour Cairns Sepsis Model (CSM-4)
consists of age, history of renal disease, number of vasopressors, Glasgow Coma Scale, lactate, bicar-
bonate, aspartate aminotransferase, lactate dehydrogenase, albumin, and magnesiumwith an area under
the receiver operating characteristic curve of 0.90 (95% confidence interval ¼ 0.84e0.95, p < 0.00001), a
Nagelkerke R2 of 0.51, specificity of 0.94, a negative predictive value of 0.98, and almost identical odds
ratios during bootstrapping. The CSM-4 outperformed existing MPMs tested on our data set. The CSM-4
also performed similar to existing MPMs in their derivation papers whilst using fewer, routinely
collected, and inexpensive variables.
Conclusions: The CSM-4 is a newly derived MPM for adults with sepsis at ICU admission. It displays
excellent discrimination, calibration, fit, specificity, negative predictive value, and bootstrapping values
whilst being easy to use and inexpensive. External validation is required.
© 2021 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).rns, QLD, Australia.
. Hargovan).
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Sepsis is defined as “life-threatening organ dysfunction due to a
dysregulated host response to infection”.1 It is a leading cause of
death globally.2,3 The annual incidence of sepsis among adult pa-
tients in Australian and New Zealand intensive care units (ICUs) is
77 cases per 100000 population, with an in-hospital mortality of
37.5%, that is, 17000 cases and more than 6000 deaths.4 It has an
estimated cost per episode of AUD 39300.5 Despite this, early
identification of adults with sepsis at risk of dying in the ICU re-
mains a challenge.6,7
Mortality prediction models (MPMs) estimate risk of death in a
patient population. As a clinical decision support tool, they can
assist clinicians in patient risk stratification, prognostication, pa-
tient outcome discussions, and shared decision-making. They can
also be used by researchers to compare clinical outcomes, compare
patient cohorts in randomised control trials, and evaluate ICUs and
improve safety and quality via the standardised mortality
ratio.8e10 Good MPMs are assessed on discrimination, commonly
measured using the area under the receiver operating characteristic
curve (AUROC), calibration as measured by a goodness-of-fit sta-
tistic such as the HosmereLemeshow c-statistic (Hos-
mereLemeshow goodness of fit [HLGOF]), and global model fit as
measured by the Nagelkerke R2 statistic (NR2). They should also be
applicable to all patients, clinically easy to use, and calculated on
inexpensive and routinely collected variables specifically for the
population of interest (i.e., sepsis).9,11,12
Several MPMs already exist in critically ill patients. However,
although these MPMs may have disease modifier codes to prog-
nosticate different diagnoses, there currently exists no MPM spe-
cifically for adults with sepsis at ICU admission who meet the
aforementioned criteria of a “good” MPM. More importantly,
existing MPMs were never designed to be used on individual pa-
tients; rather, they are designed for cohort use only.13,14 Thus, the
aim of this study was to derive an MPM, which meets the afore-
mentioned criteria of a good MPM, for use as a clinical decision
support tool on adults with sepsis by ICU clinicians within 4 hours
of ICU admission.2. Materials and methods
A retrospective cohort studywas performedwith data collection
at Cairns Hospital, a 531-bed tertiary referral centre serving a
population of approximately 240000.152.1. Ethics statement
The Human Research Ethics Committee of the Cairns and Hin-
terland Health Service District provided ethical approval for the
study (HREC/17/QCH/93/AMO2).2.2. Inclusion criteria
The first 500 consecutive adults (aged 18 years) admitted to
the ICU of Cairns Hospital between 01/01/2014 and 01/06/2018
with a diagnosis of sepsis were included. Sepsis had to be the pri-
mary admission diagnosis as per the Sepsis-3 definitions1 and
Acute Physiology and Chronic Health Evaluation (APACHE) III-j
diagnostic codes 501e504: nonurinary sepsis, urinary sepsis,
nonurinary sepsis with shock, and urinary sepsis with shock,
respectively.16 If patients were admitted on several occasions, only
their first admissionwas included. Therewere no exclusion criteria.Please cite this article as: Hargovan S et al., The 4-Hour Cairns Sepsis Mo
unit admission, Australian Critical Care, https://doi.org/10.1016/j.aucc.2022.3. Data collection
Data were collected from the Cairns Hospital ICU electronic
medical record database (MetaVision®; iMDsoft, Tel Aviv, Israel) by
four clinicians (S.H., S.S., T.G., J.B.) using a standardised data sheet. To
ensure consistency, variable definitionswere created (Table 1). Once
the data were collected, a data cleaning process was undertaken to
minimise human error manually, reviewing inputs greater than 2
standard deviations away from the mean. All variables available
within 4 hours of ICU admissionwere collected to ensure a thorough
investigation of the research question, creating a total independent
variable pool of 106. Four hourswas selected asmost laboratory and
point-of-care testing results, invasive admission procedures and
admission clerking notes were available at this time. This allowed
for optimal data collection. Collecting earlier would have resulted in
an increase in missing data. Collecting later would compromise the
models' use “on admission”, would not provide early information to
clinicians, and would not reflect changes that occur after early ICU
interventions. Variables were categorised into Predisposition,
Insult, Response, and Organ Dysfunction (PIRO) variables as per the
validated PIRO sepsis staging model.17 Our dependent variable was
ICU episode-of-care mortality.
2.4. Statistical analysis
Independent variables that had fewer than 350 inputs owing to
missing data were omitted from our analysis. These were often
variables such as troponins, C-reactive protein, and coagulation
profiles that are not routinely collected from all patients. Univariate
logistic regression using ICU episode-of-care mortality as the
dependent variable was performed as a sorting mechanism to
reduce the number of independent variables of interest before the
final analysis. Independent variables with p >0.1 were eliminated.
The remaining independent variables were tested for zero-order
correlations, defined as Pearson correlation coefficient (r) < 0.6
or >0.6 and p <0.05. A choice between variables was made if any
zero-order correlations were identified.
Multivariable backward stepwise logistic regression was per-
formed on the remaining variables to identify variables that best
correlated with ICU episode-of-care mortality. The probability for
the regression was set at p <0.01 for entry and p >0.05 for removal.
The level of significance for the final independent variables was set
to p <0.05.
Model discrimination was tested using AUROC, calibration was
tested using HLGOF, and the models' overall fit was tested using
NR2. Sensitivity, specificity, positive predictive value (PPV), and
negative predictive value (NPV) were also calculated, with a cut-off
in probability of death being 50% for the latter. A logistic regression
bootstrap procedure was deployed to further estimate internal
validation based on 2000 samples using a simple samplingmethod.
This procedure estimated the average odds ratio (OR), with 95%
confidence interval, and average p-value obtained from logistic
regression of all 2000 samples. Statistical analysis was performed
using IBM SPSS® Statistics for Windows, version 27.0, software
(IBM Corp., Armonk, NY).
3. Results
Overall, the ICU case fatality rate was 12% (n ¼ 59), the average
cohort APACHE-III-j severity score was 72, and the average age of
our cohort was 58 years. Of these, 54%were men (n¼ 272), and 35%
(n¼ 176) identified as Aboriginal or Torres Strait Islanders (Tables 2
and 3). A significant number of patients were transferred to our
centre from peripheral hospitals (n ¼ 194, 39%) and had significant




 Presumed infection: assumed when concomitant orders exist for both blood cultures and antibiotics within the time period around suspected infection.40
 SOFA baseline/admission: needs to be a rise in SOFA score >2 to meet admission criteria for study.40
 Mortality: if the patient died during an ICU admission episode.
 Smoker: either current or former with 10 cigarettes per day.
 History of alcohol use: if the patient has 4 standard drinks of alcohol per day.
 From interhospital transfer: if the patient was admitted elsewhere and then transferred to Cairns.
 From emergency department: if the patient was admitted to the ICU straight from the emergency department.
 From operating theatre: if the patient was admitted to the ICU within 24 h after surgery.
 From hospital ward: if the patient was admitted to the ICU from the hospital ward (having spent at least 4 h there).
 History of sepsis: any previous diagnosis of sepsis as per Australian ICU diagnostic coding.
 History of cardiovascular disease:41 ischaemic heart disease, stroke, heart failure (major adverse cardiac events).
 History of respiratory disease:42 chronic obstructive or restrictive lung disease.
 History of renal disease.43: chronic kidney disease or on dialysis
 History of haematological cancer:43 lymphoma, leukaemia, myeloma.
 History of gastrointestinal disease:43 cirrhosis, hepatic failure.
 History of diabetes: type 1 or type 2 diabetes.
 History of metastatic cancer:43 malignancy with metastatic disease.
 History of being immunocompromised:43 HIV/AIDS, steroids, chemotherapy, immunosuppressant medication (e.g., methotrexate, azathioprine, etc).
 Admit night: the patient was admitted after 6 pm and before 8 am.
 Site of infection, lungs/genitourinary/neurological/bones or joints/soft tissue/abdomen/other: primary site of suspected infection.
 Bacteraemia: positive blood cultures with grown organisms.
 Recent arrest: cardiac/respiratory arrest in the last 24 h
 All clinical variables/laboratory tests/procedures: taken ±4 h from time of ICU admission (take closest to admission when >1 in this period)
 Albumin ¼ calcium-corrected version obtained.
 Fibrinogen e derived fibrinogen, not clotted.
 Number of vasopressors: number of vasopressors patient was on ± 4 h from time of ICU admission.
 Admission antibiotics were antibiotics started either on or within 4 h from time of ICU admission.
 Arrhythmia: anything nonsinus excluding sinus bradycardia, sinus tachycardia, premature atrial or ventricular contractions.
S. Hargovan et al. / Australian Critical Care xxx (xxxx) xxx 3hazardous drinking (n ¼ 116, 25%), and cardiovascular disease
(n ¼ 161, 32%). Whilst the commonest source of infection was
pulmonary (33%, n ¼ 163), the commonest bug isolated was
Escherichia coli (n ¼ 68, 14%).
3.1. 4-Hour Cairns Sepsis Model
The univariate logistic regression screened out 60 independent
variables as unlikely to have a strong correlation with mortality.
There were no zero-order correlations between the remaining 42
independent variables, so they were put into the multivariable
backward stepwise regression. This resulted in a final model with
10 independent variables for the 4-Hour Cairns Sepsis Model (CSM-
4) (Table 4). The CSM-4 contained two predisposition variables,
seven acute physiology variables, and one organ dysfunction vari-
able that had an independent significant association with ICU
episode-of-care mortality for patients with sepsis within 4 hours of
ICU admission (Table 4). These are age (OR ¼ 1.4 [1.0e1.9],
P ¼ 0.045), history of renal disease (OR ¼ 3.5 [1.2e10], P ¼ 0.021),
number of vasopressors on admission (OR ¼ 2.8 [1.6e5.1],
P < 0.001), Glasgow Coma Scale (GCS) (OR ¼ 0.88 [0.81e0.96],
P¼ 0.004), lactate (OR¼ 1.5 [1.1e1.8], P¼ 0.024), bicarbonate (OR¼
1.2 [1.1e1.3], P ¼ 0.003), admission aspartate aminotransferase
(OR ¼ 0.80 for every relative 50 units/L decrease [0.69e0.92],
P ¼ 0.002), admission lactate dehydrogenase (OR ¼ 1.2 for every
relative 50 units/L increase [1.1e1.3], P< 0.001), albumin (OR¼ 0.86
[0.79e0.95], P ¼ 0.002), and admission magnesium (OR ¼ 1.4 for
every relative 0.1 mmol/L increase [1.2e1.7], P < 0.001). For the
complete model, the AUROC was 0.90 (0.84e0.95), the HLGOF was
0.081, and the NR2 was 0.51. The sensitivity was 0.79, specificity
was 0.94, NPV was 0.98, and PPV was 0.54, with a cut-off in prob-
ability of death being 50%. The bootstrap procedure confirmed
similar ORs to the ones found in the original data set (Table 4).
3.2. Comparison of the CSM-4 with other MPMs
The performance of the CSM-4 was analysed against the per-
formance of the other available MPMs in their original derivationPlease cite this article as: Hargovan S et al., The 4-Hour Cairns Sepsis Mo
unit admission, Australian Critical Care, https://doi.org/10.1016/j.aucc.202papers (Table 5). The CSM-4 had the highest discrimination (AUC ¼
0.90, p < 0.001) and overall model fit (NR2 ¼ 0.51), with good
calibration (HLGOF ¼ 0.081). It was the most recently created score
(2020) and used the third least variables (10 vs. 8 in the sequential
organ failure assessment (SOFA) score and 3 in the quick SOFA
(qSOFA) score). The CSM-4 was also compared with other available
MPMs using our patient data set (Table 6). When applied to our
patient data set, the CSM-4 had the highest discrimination and
closest calibration outperforming all other MPMs available for
comparison.
4. Discussion
The CSM-4 is a newly derived MPM for ICU clinician use, after
external validation, as a clinical decision support tool to assist in the
prediction of an individual's mortality risk from sepsis at ICU
admission. It displays good discrimination, calibration, model fit,
specificity, and NPV. It is easy to use, with only 10 routinely
collected and easily accessible variables, with no complex calcula-
tions or interventions needed.
4.1. MPMs: an overview
The increasing use of electronic medical records and techno-
logical advancements have created large amounts of data.
Extracting and analysing useful data can enable progress in clinical
decision-making, ultimately improving patient outcomes.18 Despite
sepsis having both high ICU incidence and case fatality rate, the
identification of patients with sepsis at risk of dying remains a
challenge, and information regarding early predictive factors for
mortality is limited.19 The rapid, precise prediction of poor
outcomes via an MPM may support clinicians in clinical decision-
making.18 One such clinical use of an MPM is patient risk stratifi-
cation, wherein patients at highrisk of mortality could be consid-
ered for escalation of care or more aggressive therapy, considered
for closer monitoring for clinical deterioration, and considered for
advance care planning discussions.20,21 Furthermore, a good MPM
may assist clinicians in patient outcome discussions and informingdel: A novel approach to predicting sepsis mortality at intensive care
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Table 2
Binary independent variables describing patient admission characteristics.
Independent variables (binary) Patient statistics
Number of patients Distribution %
Predisposition
Male gender 500 272 54
Indigenous 500 176 35
From interhospital transfer 500 194 39
From emergency department 500 158 32
From nursing home 500 0 0.00
From surgical theatre 500 6 1.2
From hospital ward 499 142 29
>4 standard drinks of alcohol/day 461 116 25
Smoker >10 cigarettes/day 460 243 53
History of sepsis 430 86 20
History of cardiovascular disease 497 161 32
History of respiratory disease 497 91 18
History of renal disease 497 95 19
History of haematological cancer 496 45 9.1
History of gastrointestinal disease 497 43 8.7
History of diabetes 497 176 35
History of metastatic cancer 498 42 8.4
History of being immunocompromised 498 70 14
Admitted at night 500 307 61
Recent cardiac arrest 500 15 3.0
Statin use 498 138 28
Infection
Site of infection, lungs 492 163 33
Site of infection, genitourinary 492 105 21
Site of infection, neuro 492 5 1.0
Site of infection, bones/joints 492 13 2.6
Site of infection, soft tissue 492 96 19
Site of infection, abdomen 492 67 14
Gram-negative bacteria 439 206 47
Gram-positive bacteria 440 152 35
Bacterial 443 314 71
Fungal 443 17 3.8
Viral 442 32 7.2
Bacteraemia 478 198 41
E. coli 500 68 14
S. aureus 500 60 12
Methicillin-resistant S. aureus 500 17 3.4
P. aeruginosa 500 41 8.2
K. pneumonia 500 24 4.8
Influenza A 500 17 3.4
B. pseudomallei 500 17 3.4
S. pyogenes 500 26 5.2
Leptospirosis 500 11 2.2
S. pneumonia 500 15 3.0
P. jirovecii 500 6 1.2
Organ dysfunction
Dose of vasopressors >1 mcg/kg/min 389 160 41
Admission antibiotics 499 488 98
Intubated 499 101 20
Peripherally inserted central catheter 498 149 30
Central venous line 500 206 41
Arterial line 500 413 83
Nasogastric tube 500 101 20
Indwelling catheter 500 418 84
Continuous renal replacement therapy 497 111 22
S. Hargovan et al. / Australian Critical Care xxx (xxxx) xxx4care discussions and shared decision-making. They may also assist
researchers in comparing patient cohorts in randomised control
trials9 and healthcare governance by allowing evaluation of ICU
performance and improvement of safety and quality of ICU care via
calculation of the standardised mortality ratio.22,23
Before an MPM is considered for use, it should be assessed on a
discrimination measurement such as the AUROC, a calibration
measurement such as a goodness-of-fit statistic such as the HLGOF,
and a global model fit statistic such as NR2. They should also be
applicable to all patients, clinically easy to use, and calculated on
cheap and routinely collected variables specifically for the popu-
lation of interest (i.e., sepsis).9,11,12 Minimal data requirementsPlease cite this article as: Hargovan S et al., The 4-Hour Cairns Sepsis Mo
unit admission, Australian Critical Care, https://doi.org/10.1016/j.aucc.202lighten the burden of implementation in a clinical setting and
broaden its application.24 Before use, MPMs should also be appro-
priately externally validated. To remain relevant, risk scores need to
be updated to reflect evolutions in diagnostics and
therapeutics.18,24
4.2. Assessing current MPMs
There are many MPMs described in the literature for use in the
ICU. These can be divided into general and disease-specific ones
(i.e., sepsis). General MPMs include the APACHE,25 simplified acute
physiology score (SAPS)26 and MPM scores,27 whereas the mostdel: A novel approach to predicting sepsis mortality at intensive care
0.12.007
Table 3
Continuous independent variables describing patient admission characteristics.
Independent variables (continuous) Distribution
Number of patients Mean (standard deviation); median (interquartile range)
Predisposition
Age (years) 500 58 (16); 60 (48e69)
Body mass index 494 30 (9.1); 28 (23e33)
Infection
Number of organisms 478 0.98 (0.83); 1.0 (0e1)
Response
Heart rate (beats per minute) 499 100 (23); 99 (84e115)
Systolic blood pressure (mmHg) 499 109 (21); 07 (95e121)
Mean arterial blood pressure (mmHg) 499 74 (14.6); 73 (65e83)
Diastolic blood pressure (mmHg) 499 61 (14.4); 60 (51e68)
Temperature (degree Celsius) 498 37 (0.98); 37 (37-37)
Respiratory rate (breaths per minute) 499 22 (6.6); 20 (17e25)
Oxygen saturation (percentage) 498 96 (3.9); 97 (95e99)
Glasgow Coma Scale score (out of 15) 496 13 (4.2); 97 (14e15)
Blood sugar level (mmol/L) 488 7.7 (3.5); 6.6 (5.3e9)
Number of vasopressors 459 1.03 (0.78); 1 (1-1)
Dose of vasopressor, more than 1 mcg/min 389 1.3 (0.66); 1 (1e2)
Fraction of inspired oxygen (%) 474 42 (26); 30 (21e50)
Lactate (mmol/L) 448 2.4 (2.1); 1.8 (1.1e3)
Alveolarearterial gradient (mmHg) 217 183 (179); 127 (54e292)
pH 462 7.3 (0.13); 7.4 (7.3e7.4)
Partial pressure of CO2 (mmHg) 459 36 (12); 34 (28e41)
Bicarbonate (mmol/L) 464 19 (5.5); 19 (16e22)
Base excess (mEq/L) 462 6.3 (6.4); 5.2 (9 -(-2.5))
Anion gap (mEq/L) 439 9.8 (4.3); 9 (7e12)
Partial pressure of O2 (mmHg) 446 93 (54); 81 (70e99)
Partial pressure of O2:fraction of inspired O2 420 282 (137); 285 (166e384)
Oxygenated haemoglobin (%) 421 92 (10); 94 (92e96)
Carboxylated haemoglobin (%) 389 0.74 (0.68); 0.5 (0.3e1)
Methaemoglobin (%) 355 0.38 (0.53); 0.3 (0.2e0.4)
Haemoglobin (g/L) 424 107 (24); 107 (89e124)
Red cell count (1012/L) 418 3.7 (0.82); 3.7 (3.1e4.3)
Haematocrit (L/L) 420 0.33 (0.71); 0.32 (0.27e0.37)
Mean cell volume (fL) 417 88 (7.6); 88 (83e93)
White cell count (109/L) 415 17 (12); 14 (8.4e22)
Neutrophils (109/L) 416 14 (10); 11 (6.4e19)
Eosinophils (109/L) 416 0.15 (1.9); 0 (0e0.4)
Basophils (109/L) 416 0.018 (0.041); 0.0 (0.0e0.02)
Monocytes (109/L) 414 0.85 (1.2); 0.6 (0.3e1.2)
Lymphocytes (109/L) 415 1.2(1.5); 0.82 (0.42e1.4)
Platelets (109/L) 397 184 (113); 171 (103e245)
C-reactive protein (mg/L) 167 195 (133); (80e290)
Troponin I (mcg/L) 117 1.7 (5.4); 0.12 (0.041e0.38)
Prothrombin time (s) 349 18 (10); 16 (14e18)
Activated partial thromboplastin Time (s) 345 40 (15); 37 (32e43)
International normalised ratio 348 1.6 (0.81); 1.4 (1.3e1.6)
Fibrinogen (mg/dL) 346 6.6 (2.5); 6.5 (4.8e8.2)
Aspartate aminotransferase (U/L) 419 136 (343); 51 (24e109)
Alanine aminotransferase (U/L) 418 71 (146); 33 (18e63)
Gamma-glutamyl transferase (U/L) 424 75 (101); 48 (25e94)
Alkaline phosphatase (U/L) 424 110 (94); 85 (61e126)
Lactate dehydrogenase (U/L) 410 466 (633); 330 (243e452)
Conjugated bilirubin (mmol/L) 329 17 (23); 8 (8e18)
Total bilirubin (mmol/L) 423 29 (32); 19 (13e31)
Albumin (g/L) 408 25 (5.2); 25 (21e28)
Protein (mg/L) 424 56 (9.51); 55 (49e62)
Creatinine (mmol/L) 424 219 (247); 29 (80e262)
Urea (mmol/L) 403 13 (12); 9.4 (5.6e17)
Estimated glomerular filtration rate (mL/min/1.73 m2) 354 41 (27); 38 (16e63)
Osmolality (mmol/kg) 416 288 (16); 287 (279e295)
Calcium (mmol/L) 412 2.2 (0.2); 2.2 (2.1e2.3)
Phosphate (mmol/L) 423 1.4 (0.77); 1.2 (0.91e1.8)
Magnesium (mmol/L) 424 0.77 (0.20); 0.74 (0.65e0.87)
Sodium (mmol/L) 430 134 (5.1); 135 (131e137)
Potassium (mmol/L) 427 4.2 (0.82); 4.1 (3.7e4.6)
Chloride (mmol/L) 427 104 (6.4); 104 (100e108)
Organ dysfunction
Minute ventilation (mL/min) 98 7.8 (2.0); 7.8 (6.5e9.0)
Urine output at 4 h (mL) 495 378 (430); 255 (100e517)
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Table 4
4-Hour cairns sepsis model (CSM-4).





P-valuea Odds ratio (95% CI)a
Predisposition
Age (decade) 500 0.018 1.3 (1.0e1.5) 0.045/0.043 1.4 (1.0e1.9)/1.4 (1.0e2.2)
Male gender 500 0.42 1.3 (0.72e2.2)
Indigenous 500 0.82 0.94 (0.53e1.7)
Socio-economic status 416 0.44 1.0 (0.99e1.0)
From interhospital transfer 500 0.41 0.79 (0.44e1.4)
From emergency department 500 0.43 0.78 (0.43e1.4)
From nursing home 500 e e
From surgical theatre 500 1.00 0.00 (0.00ef)
From hospital ward 499 0.059 1.7 (0.98e3.0)
>4 standard drinks of alcohol per day 461 0.64 0.85 (0.42e1.7)
Smoker 460 0.97 1.0 (0.56e1.8)
History of sepsis 430 0.81 0.91 (0.40e2.0)
History of cardiovascular disease 497 0.066 1.7 (0.97e3.0)
History of respiratory disease 497 0.22 1.5 (0.78e2.9)
History of renal disease 497 0.17 1.6 (0.83e3.0) 0.021/0.027 3.5 (1.2e10)/3.5 (0.92e15)
History of haematological cancer 496 0.19 1.7 (0.77e3.9)
History of gastrointestinal disease 497 0.99 1.0 (0.38e2.6)
History of diabetes 497 0.47 1.2 (0.70e2.2)
History of metastatic cancer 498 0.14 1.9 (0.82e4.3)
History of being immunocompromised 498 0.28 1.5 (0.73e3.0)
Admitted at night 500 0.43 1.3 (0.71e2.2)
BMI 494 0.93 0.99 (0.97e1.0)
Recent cardiac arrest 500 0.0000030 13 (4.5e38)
Infection
Site of infection, lungs 492 0.088 1.6 (0.93e2.8)
Site of infection, genitourinary 492 0.072 0.47 (0.21e1.1)
Site of infection, neuro 492 1.00 0.00 (0.00-f)
Site of infection, bones/joints 492 1.00 0.00 (0.00ef)
Site of infection, soft tissue 492 0.81 1.1 (0.55e2.1)
Site of infection, abdomen 492 0.39 1.4 (0.66e2.9)
Gram-negative bacteria 439 0.78 0.92 (0.51e1.7)
Gram-positive bacteria 440 0.91 1.0 (0.56e1.9)
Bacterial 443 0.35 1.4 (0.70e2.7)
Fungal 443 0.026 3.4 (1.2e10)
Viral 442 0.69 0.78 (0.23e2.7)
Bacteraemia 478 0.72 1.1 (0.63e2.0)
No. of organisms cultured 478 0.84 1.3 (0.96e1.8)
Response
Heart rate (beats per minute) 499 0.19 1.0 (1.0e1.0)
Systolic blood pressure (mmHg) 499 0.067 0.99 (0.97e1.0)
Mean arterial blood pressure (mmHg) 499 0.27 0.99 (0.97e1.0)
Diastolic blood pressure (mmHg) 499 0.29 0.99 (0.97e1.0)
Temperature (degree Celsius) 498 0.0000090 0.51 (0.38e0.69)
Respiratory rate (breaths per minute) 499 0.058 0.96 (0.92e1.0)
Oxygen saturation (percentage) 498 0.0040 0.92 (0.87e0.97)
Glasgow Coma Scale score (out of 15) 496 <0.000001 0.85 (0.81e0.90) 0.0039/0.0030 0.88 (0.81e0.96)/0.88 (0.79e0.96)
Blood sugar level (mmol/L) 488 0.43 1.0 (0.96e1.1)
Fraction of inspired oxygen (%) 474 0.000096 1.0 (1.0e1.0)
Lactate (mmol/L) 448 <0.000001 1.4 (1.3e1.6) 0.0024/<0.001 1.5 (1.1e1.8)/1.5 (1.2e1.9)
Alveolarearterial gradient (mmHg) 217 0.000006 1.0 (1.0e1.0)
pH 462 <0.000001 0.010 (0.00e0.060)
Partial pressure of CO2 (mmHg) 464 0.0040 1.0 (1.0e1.0)
Bicarbonate (mmol/L) 464 0.017 0.94 (0.90e0.99) 0.0034/0.0030 1.2 (1.1e1.3)/1.2 (1.1e1.3)
Base excess (mEq/L) 462 0.000073 0.93 (0.89e0.96)
Anion gap (mEq/L) 439 0.0060 1.1 (1.0e1.2)
Partial pressure of O2 (mmHg) 446 0.63 1.0 (1.0e1.0)
Partial pressure of O2:fraction of inspired O2 420 0.0010 1.0 (0.99e1.0)
Oxygenated haemoglobin (%) 421 0.67 0.99 (0.97e1.0)
Carboxylated haemoglobin (%) 389 0.51 1.2 (0.77e1.7)
Methaemoglobin (%) 355 0.67 0.82 (0.33e2.0)
Haemoglobin (g/L) 371 0.59 1.0 (0.99e1.0)
Red cell count (1012/L) 418 0.76 0.95 (0.66e1.4)
Haematocrit (L/L) 420 0.72 0.47 (0.01e29)
Mean cell volume (fL) 417 0.42 1.0 (0.98e1.1)
White cell count (109/L) 415 0.57 1.0 (0.98e1.0)
Neutrophils (109/L) 416 0.44 1.0 (0.98e1.0)
Eosinophils (109/L) 416 0.79 0.93 (0.55e1.6)
Basophils (109/L) 416 0.14 71 (0.26e1.9  104)
Monocytes (109/L) 414 0.17 1.1 (0.95e1.4)
Lymphocytes (109/L) 415 0.81 1.1 (0.98e1.3)
Platelets (109/L) 397 0.086 1.0 (0.99e1.0)
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Table 4 (continued )





P-valuea Odds ratio (95% CI)a
C-reactive protein (mg/L) 167 0.093 1.0 (1.0e1.0)
Troponin I (mcg/L) 117 0.041 1.1 (1.0e1.2)
Prothrombin time (s) 349 0.0020 1.0 (1.0e1.1)
Activated partial thromboplastin time (s) 345 0.00011 1.0 (1.0e1.1)
International normalised ratio 348 0.0010 1.7 (1.3e2.3)
Fibrinogen (mg/dL) 346 0.79 1.0 (0.90e1.1)
Aspartate aminotransferase (U/L) e change >50 units 419 0.0060 1.0 (1.0e1.1) 0.0022/<0.001 0.80 (0.69e0.92)/0.80 (0.65e0.90)
Alanine aminotransferase (U/L) 418 0.16 1.0 (1.0e1.0)
Gamma-glutamyl transferase (U/L) 424 0.65 1.0 (1.0e1.0)
Alkaline phosphatase (U/L) 424 0.10 1.0 (1.0e1.0)
Lactate dehydrogenase (U/L) e change >50 units 410 0.00042 1.0 (1.0e1.1) 0.00027/<0.001 1.2 (1.1e1.3)/1.2 (1.1e1.3)
Conjugated bilirubin (mmol/L) 329 0.0010 1.0 (1.0e1.0)
Total bilirubin (mmol/L) 423 0.0010 1.0 (1.0e1.0)
Albumin (g/L) 408 0.000074 0.87 (0.81e0.93) 0.0022/0.010 0.86 (0.79e0.95)/0.86(0.73e0.96)
Protein (mg/L) 424 0.014 0.96 (0.93e0.99)
Creatinine (mmol/L) 424 0.18 1.0 (1.0e1.0)
Urea (mmol/L) 403 0.045 1.0 (1.0e1.0)
Estimated glomerular filtration rate (mL/min/1.73 m2) 354 0.14 0.99 (0.98e1.0)
Osmolality (mmol/kg) 416 0.020 1.0 (1.0e1.0)
Calcium (mmol/L) 412 0.10 0.29 (0.07e1.3)
Phosphate (mmol/L) 423 <0.000001 2.4 (1.8e3.4)
Mg_0.1 e change >0.1 unit 424 0.000014 1.3 (1.2e1.5) 0.00081/<0.001 1.4 (1.2e1.7)/1.4 (1.2-)
Sodium 430 0.94 1.0 (0.94e1.1)
Potassium 427 0.018 1.5 (1.1e2.0)
Chloride 427 0.12 0.97 (0.92e1.0)
Organ dysfunction
No. of vasopressors 499 <0.000001 3.3 (2.3e4.7) 0.00066/<0.001 2.8 (1.6e5.1)/2.8 (1.5e7.3)
Antibiotics on admission 499 0.51 0.60 (0.13e2.8)
Intubated 499 <0.000001 5.9 (3.3e10)
Minute ventilation 98 0.80 0.97 (0.78e1.2)
Peripherally inserted central catheter 498 0.42 0.78 (0.42e1.4)
Central venous line 500 0.0070 2.1 (1.2e3.6)
Arterial line 500 0.24 1.7 (0.72e3.8)
Nasogastric tube 500 0.0000040 3.9 (2.2e6.8)
Indwelling catheter 500 0.90 0.96 (0.46e2.0)
Continuous renal replacement therapy 499 0.0080 2.6 (1.3e5.4)
Urine output over 4 h e change of 50 mL 487 0.00023 0.88 (0.82e0.94)
CI ¼ confidence interval.
a The first value is from the original data set. The second value (after forward slash) is the average outcome from regression of 2000 bootstrap samples.
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SOFA28 and qSOFA score.1 Although general MPMs have their
strengths, they are not sepsis-specific investigate variables such as
organ dysfunction or acute physiology in isolation.29 The accuracy
of general MPM use in patient subgroups (i.e., sepsis) is therefore
suboptimal, and disease-specific scoring systems are ideal.
Furthermore, general MPMs use not only more variables but also
those that are not routinely collected or easily accessible. Clinicians
are unlikely to use complex MPMs that require collection of
extensive or expensive information that impedes
workflow.21,22 The sepsis-specific SOFA score was developed over
20 years ago by expert consensus. Although it can predict mortality
based on organ dysfunction variables, this is not what it wasTable 5
Comparison between CSM-4 and the original articles of other MPMs.
MPMs AUROC Nagelkerke R2 HLGOF
CSM-4 hr 0.90, p ¼ 1.5  1016 0.51 0.081
APACHE-IV 0.88, p ¼ not given Not given 0.80
SOFA 0.88, p ¼ not given Not given 0.80
SAPS-III 0.85, p ¼ not given Not given 0.39
MPMo-III 0.82, p ¼ not given Not given 0.31
qSOFA 0.61, p ¼ not given Not given Not giv
APACHE¼ Acute Physiology and Chronic Health Evaluation; CSM-4¼ 4-Hour Cairns Sepsi
physiology score; qSOFA ¼ quick SOFA score; MPM ¼ mortality prediction model; HLGOF
characteristic curve.
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measuring organ dysfunction alone.24 Furthermore, the SOFA score
requires numerous calculations and invasive tests that may
dissuade clinician use.30 The qSOFA score was designed as a ward-
based sepsis screening tool rather than as an ICU MPM.1 When
applied to adults with sepsis at ICU admission, the qSOFA was not
an effective ICU MPM, and hence, its use may be limited outside its
intended scope. Furthermore, a literature review evaluating all ICU
MPMs investigated 94 studies on 240 assessments of 118 MPMs
found that the AUROC of MPMs ranged markedly from 0.43 to 0.98
(median ¼ 0.77) and that most documented MPMs have limited
clinical utility.22 Overall, the ideal sepsis MPM therefore remains to
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sModel; SOFA¼ seequential organ failure assessment socre; SAPS¼ simplified acute
¼ HosmereLemeshow goodness of fit; AUROC ¼ area under the receiver operating
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Table 6
Comparison of other MPMs with CSM-4 using our data set.
MPMs AUROC (95% Cl) Nagelkerke R2 HLGOF P-value No. of variables
CSM-4 hr 0.90 (0.84e0.95) 0.51 0.081 1.5  1016 10
APACHE-II 0.69 (0.59e0.79) 0.12 0.59 7.4  108 17
APACHE-III-j 0.77 (0.69e0.85) 0.20 0.80 4.8  1017 26
SOFA 0.78 (0.72e0.85) 0.20 0.54 1.4  109 8
SAPS-II 0.81 (0.75e0.87) 0.24 0.19 7.6  1011 17
MPM II-24 hr 0.82 (0.72e0.85) 0.26 0.50 6.7  107 15
qSOFA 0.60 (0.50e0.70) 0.017 0.20 0.062 3
APACHE ¼ Acute Physiology and Chronic Health Evaluation; CSM-4 ¼ 4-Hour Cairns Sepsis Model; MPM ¼ mortality prediction model; HLGOF ¼ HosmereLemeshow
goodness of fit; AUROC ¼ area under the receiver operating characteristic curve; CI ¼ confidence interval.
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The internal validation of the CSM-4 shows excellent discrimi-
nation, calibration, and overall performance well above the median
ICU MPM AUROC of 0.77.9,22 Furthermore, the bootstrap procedure
produced similar ORs to the original data set, suggesting that
overfitting is not a major problem in the presented CSM-4. Derived
in 2020, the CSM-4 is the most recent MPM. It uses routinely
collected variables that are all available within 4 hours of ICU
admission, without any need for overly invasive testing or complex
calculations, making it clinically easy to use. In terms of cost, the
collection of details such as age, history of renal disease, number of
vasopressors used, and GCS requires simple beside clinical history
taking, examination and routine laboratory costsmaking this a
relatively inexpensive MPM to use.
Sepsis is a complex and heterogeneous syndrome. The PIRO
concept has been validated as a way of sifting through the
complexity and staging sepsis. Each of the four PIRO components
predict in-hospital mortality, but they provide greater predictive
accuracy when combined.17 True to this finding, three of the four
components of the PIRO model, namely, predisposition, physio-
logical response, and organ dysfunction variables, were included in
the CSM-4. Sepsis mortality, therefore, may be suboptimally pre-
dicted by organ dysfunction scores, such as the SOFA, or predom-
inantly acute physiological scores, such as the general MPMs,
alone.17 The presence of acute hepatic, neurological, and cardio-
vascular system derangement was included in the final model,
reaffirming the significance of multiorgan failure as a hallmark of
critically unwell sepsis. The links between increasing age,32 serum
lactate levels,1,2 serum lactate dehydrogenase levels33 vasopressor
use,34 a history of renal disease35, decreasing GCS score1,2, and al-
bumin levels36 with sepsis mortality are already well described in
the literature. Whilst to the best of our knowledge, there are no
studies linking either increasing serum bicarbonate or serum
magnesium levels to sepsis mortality, increased serum bicarbonate
and magnesium levels independently predict ICU mortality. Rea-
sons for this are unknown, but may include overly aggressive
replacement in those who are already at high risk of
dying.37,38 Decreasing serum aspartate aminotransferase levels
were also a predictor of sepsis mortality. Again, although the cause
of this is unknown, patients with a history of renal disease are
known to have reduced serum transaminase levels.39 Further
research into the pathophysiology of how the statistically signifi-
cant variables predict sepsis mortality may broaden clinicians'
understanding of sepsis diagnosis, prognosis, and management.4.4. Strengths and limitations
Themajor strength of this study is the derivation of anMPM that
can be applied to patients with sepsis at ICU admission to assist
clinicians in determining episode-of-care mortality risk. It showsPlease cite this article as: Hargovan S et al., The 4-Hour Cairns Sepsis Mo
unit admission, Australian Critical Care, https://doi.org/10.1016/j.aucc.202good discrimination, calibration, fit, specificity, and NPV, which is
further supported by a bootstrapping procedure. The evaluation of
106 variables ensured an in-depth and thorough approach to
determine which variables at ICU admission correlated best to ICU
episode-of-care mortality. The CSM-4 is easy to use, with only 10
routinely collected and easily accessible variables, at a relatively
inexpensive cost allowing for easier potential future translation
into clinical practice and research.
Limitations include using one site and a modest cohort.
Furthermore, not all variables were always routinely collected
within 4 hours, making analysis of these inadequately powered and
limiting the conclusions drawn. The SOFA and qSOFA scores were
not able to be accurately estimated for patients on sedatives owing
to the retrospective nature of data collection, and these patients
were excluded from the assessment of these respective scores. As
the focus of this article was model derivation, our model has not
been externally validated. Future research should focus on the
external validation of the model using a prospective multisite
approach, as well as on investigation of ability of the CSM-4 to
predict other equally important metrics such as length of stay,
morbidity, and post-ICU outcomes.
5. Conclusions
This single-cohort study derived the CSM-4, a sepsis-specific
MPM, for use on adults with sepsis at ICU admission. It displays
good discrimination, calibration, model fit, specificity, and NPV
whilst being easy to use and inexpensive. As a clinical decision
support tool, it may assist clinicians with prognostication, risk
stratification, shared decision-making, cohort comparison, and the
provision of safe and high-quality ICU care. External validation is
required.
CRediT authorship contribution statement
Satyen Hargovan: Conceptualisation, Data curation, Formal
analysis, Methodology, Project administration, Writing - original
draft; Ronny Gunnarsson: Conceptualisation, Formal analysis,
Methodology, Project administration, Supervision; Angus Carter:
Conceptualisation, Methodology, Project administration, Supervi-
sion; Alan De Costa: Conceptualisation, Methodology, Project
administration, Supervision; James Brooks: Data curation, Writing
- review & editing; Taissa Groch: Data curation, Writing - review&
editing; Sayonne Sivalingam: Data curation, Writing - review &
editing.
Authors statement
All work on this paper is original. All authors were involved in
the submission process and take responsibility for the published
piece.del: A novel approach to predicting sepsis mortality at intensive care
0.12.007
S. Hargovan et al. / Australian Critical Care xxx (xxxx) xxx 9Funding
This research did not receive any specific grant from funding
agencies in the public, commercial, or not-for-profit sectors.Conflict of interest
None declared.References
[1] Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschmann CS,
et al. Developing a new definition and assessing new clinical criteria for septic
shock: for the third international consensus definitions for sepsis and septic
shock (Sepsis-3). JAMA 2016;315:775e87.
[2] Seymour CW, Liu VX, Iwashyna TJ, Bronkhurst FM, Rea TD, Scherag Andre,
et al. Assessment of clinical criteria for sepsis: for the third international
consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315:
762e74.
[3] Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P,
et al. Assessment of global incidence and mortality of hospital-treated sepsis.
Current estimates and limitations. Am J Respir Crit Care Med 2016;193:
259e72.
[4] Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J, et al. Adult pop-
ulation incidence of severe sepsis in Australian and New Zealand Intensive
Care Units. Intensive Care Med 2004;30:589e96.
[5] Australian Sepsis Network. Sepsis epidemiology [Internet]. Australia. The
George Institute for Global Health. Date unknown [updated 2020; cited 2020
Aug 8]. Available from: https://www.australiansepsisnetwork.net.au/
healthcare-providers/sepsis-epidemiology.
[6] Vincent JL. The clinical challenge of sepsis identification and monitoring. PLoS
Med 2016;13(5):e1002022. https://doi.org/10.1371/journal.pmed.1002022.
[Accessed 13 August 2018].
[7] Mohan A, Shrestha P, Guleria R, Mohan Pandey R, Wig N. Development of a
mortality prediction formula due to sepsis/severe sepsis in a medical intensive
care unit. Lung India 2015;32(4):313e9.
[8] Sadaka F, EthmaneAbouElMaali C, Cytron MA, Fowler K, Javaux JM, O’Brien J.
Predicting mortality of patients with sepsis: a comparison of Apache II and
Apache III scoring systems. J Clin Med Res 2017;9(11):907e10. https://doi.org/
10.14740/jocmr3083w.
[9] Lee J, Dubin JA, Maslove DM. Mortality prediction in the ICU. In: Secondary
analysis of electronic Health records. Cham: Springer; 2016. https://doi.org/
10.1007/978-3-319-43742-2_21.
[10] Garcia-Simon M, Morales JM, Modesto-Alapont V, Gonzalez-Marrachelli V,
Vento-Rehues R, Jorda-Minana A, et al. Prognosis biomarkers of severe sepsis
and septic shock by 1H NMR urine metabolomics in the intensive care unit.
PloS One 2015;10(11):e0140993.
[11] Bouch DC, Thompson JP. Severity scoring systems in the critically ill. Cont
Educ Anaesth Crit Care Pain 2008;8(5):181e5.
[12] Khwannimit B, Bhurayanontachai R, Vattanavanit V. Validation of the Sepsis
Severity Score compared with updated severity scores in predicting hospital
mortality in sepsis patients. Shock 2017;47:720e5. https://doi.org/10.1097/
SHK.0000000000000818.
[13] Arabi Y, Shirawi NA, Memish Z, Srinivas V, Al-Shimemeri A. Assessment of six
mortality prediction models in patients admitted with severe sepsis and
septic shock to the intensive care unit: a prospective cohort study. Crit Care
2003;7(5):R116e22.
[14] Hamilton F, Arnold D, Baird A, Albur M, Whiting P. Early Warning Scores do
not accurately predict mortality in sepsis: a meta-analysis and systematic
review of the literature. J Infect 2018;76(3):241e8. https://doi.org/10.1016/
j.jinf.2018.01.002.
[15] Australian Bureau of Statistics. Census QuickStats e XX. [Internet]. 2016. 2016
[cited 2020 April 5]. Available from: https://quickstats.censusdata.abs.gov.au/
census_services/getproduct/census/2016/quickstat/306.
[16] Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al.
The Apache III prognostic system. Risk prediction of hospital mortality for
critically ill hospitalized adults. Chest 1991;100:1619e36.
[17] Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/
ESICM/ACCP/ATS/SIS.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis
definitions conference. Crit Care Med 2003;31:1250e6.
[18] Arzeno NM, Lawson KA, Duzinski SV, Vikalo H. Designing optimal mortality
risk prediction scores that preserve clinical knowledge. J Biomed Inf 2015;56:
145e56. pmid:26056073.
[19] Mohamed AKS, Mehta AA, James P. Predictors of mortality of severe sepsis
among adult patients in the medical Intensive Care Unit. Lung India
2017;34(4):330e5. https://doi.org/10.4103/lungindia.lungindia_54_16.Please cite this article as: Hargovan S et al., The 4-Hour Cairns Sepsis Mo
unit admission, Australian Critical Care, https://doi.org/10.1016/j.aucc.202[20] Taylor SP, Chou SH, McWilliams AD, Russo M, Heffner AC, Murphy S, et al. The
effect of outcome selection on the performance of prediction models in pa-
tients at risk for sepsis. Crit Care Explor 2020;2(1):e0078. https://doi.org/
10.1097/CCE.0000000000000078. Published 2020 Jan 29.
[21] Cowen ME, Czerwinski JL, Posa PJ, Van Hoek E, Mattimore J, Halasyamini LK,
et al. Implementation of a mortality prediction rule for real-time decision
making: Feasibility and validity. J Hosp Med 2014;11:720e6. https://doi.org/
10.1002/jhm.2250.
[22] Siontis GCM, Tzoulaki I, Ioannidis JPA. Predicting death: an empirical evalu-
ation of predictive tools for mortality. Arch Intern Med 2011;171(19):1721e6.
https://doi.org/10.1001/archinternmed.2011.334.
[23] Ben-Tovim DI, Pointer SC, Woodman R, Hakendorf PH, Harrison JE. Routine
use of administrative data for safety and quality purposesdhospital mortality.
Med J Aust 2010 Oct;193:S100e3.
[24] Mao Q, Jay M, Hoffman JL, Calvert J, Barton C, Shimabukuro D, et al. Multi-
centre validation of a sepsis prediction algorithm using only vital sign data in
the emergency department, general ward and ICU. BMJ Open 2018;8:
e017833. https://doi.org/10.1136/bmjopen-2017-017833.
[25] Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and
Chronic Health Evaluation (Apache) IV: hospital mortality assessment for
today’s critically ill patients. Crit Care Med 2006;34:1297e310.
[26] Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Abizanda-Campos R,
et al. SAPS 3 - from evaluation of the patient to evaluation of the intensive
care unit. Part 2: development of a prognostic model for hospital mortality at
ICU admission. Intensive Care Med 2005;31:1345e55.
[27] Higgins TL, Teres D, Copes WS, Nathanson BH, Stark M, Kramer AA. Assessing
contemporary intensive care unit outcome: an updated Mortality Probability
Admission Model (MPM0-III). Crit Care Med 2007;35:827e35.
[28] Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al.
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ
dysfunction/failure. Intensive Care Med 1996;22:707e10.
[29] Vincent J-L, Moreno R. Clinical review: scoring systems in the critically ill. Crit
Care 2010;14(2):207.
[30] Gupta T, Puskarich MA, DeVos E, Javed A, Smotherman C, Sterling SA, et al.
Sequential organ failure assessment component score prediction of in-hos-
pital mortality from sepsis. J Intensive Care Med 2018. https://doi.org/
10.1177/0885066618795400. epub885066618795400.
[31] Kovach CP, Fletcher GS, Rudd KE, Grant RM, Carlbom DJ. Comparative prog-
nostic accuracy of sepsis scores for hospital mortality in adults with suspected
infection in non-ICU and ICU at an academic public hospital. PloS One
2019;14(9):e0222563. https://doi.org/10.1371/journal.pone.0222563.
[32] Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med
2013;369(9):840e51. 2013.
[33] Zein J, Lee G, Tawk M, Mohammed D, Kinasewitz GJ. Prognostic significance of
elevated serum lactate dehydrogenase (LDH) in patients with severe sepsis.
Chest 2004;126:S873.
[34] Vallabhajosyula S, Jentzer JC, Kotecha AA, Murphree Jr DH, Barreto EF,
Khanna AK, et al. Development and performance of a novel vasopressor-
driven mortality prediction model in septic shock. Ann Intensive Care 2018;8:
112. https://doi.org/10.1186/s13613-018-0459-6.
[35] Mansur A. Chronic kidney disease is associated with a higher 90-day mortality
than other chronic medical conditions in patients with sepsis. Sci Rep 2015;5:
10539. https://doi.org/10.1038/srep10539.
[36] Kendall H, Abreu E, Cheng AL. Serum albumin trend is a predictor of mortality
in ICU patients with sepsis. Biol Res Nurs 2019;21(3):237e44. https://doi.org/
10.1177/1099800419827600.
[37] Liborio AB, Noritomi DT, Leite TT, De Melo Bezerra CT, De Faria ER, Kellum JA.
Increased serum bicarbonate in critically ill patients: a retrospective analysis.
Intensive Care Med 2015;41:479e86. https://doi.org/10.1007/s00134-015-
3649-9.
[38] Escuela MP, Guerra M, A~non JM, Martinez-Vizcaino V, Zapatero MD, Garcia-
Jalon A, et al. Total and ionized serum magnesium in critically ill patients.
Intensive Care Med 2005;31:151e6. https://doi.org/10.1007/s00134-004-
2508-x.
[39] Sette LH, Almeida-Lopes EP. Liver enzymes serum levels in patients with
chronic kidney disease on hemodialysis: a comprehensive review. Clinics
2014;69(4):271e8. https://doi.org/10.6061/clinics/2014(04)09.
[40] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M.
The third international consensus definitions for sepsis and septic shock
(Sepsis-3). JAMA 2016;315(8):801e10.
[41] Arnott C, Li Q, Kang A, Neuen BL, Bompoint S, Lam CSP. Sodium-glucose
cotransporter 2 inhibition for the prevention of cardiovascular events in pa-
tients with type 2 diabetes mellitus: a systematic review and meta-analysis. J
Am Heart Assoc 2020;9(3):e014908. https://doi.org/10.1161/JAHA.119.
014908.
[42] Knaus WA, Draper EA, Wagner DP. APACHE II: a severity of disease classifi-
cation system. Crit Care Med 1985;13(10):818e29.
[43] Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute physiology and
chronic health evaluation (apache) iv: hospital mortality assessment for to-
day’s critically ill patients. Crit Care Med 2006;34:1297e310.del: A novel approach to predicting sepsis mortality at intensive care
0.12.007
